数位糖尿病管理的全球市场:各产品类型，各终端用户，各零件，各地区，范围及预测

数位糖尿病管理市场规模及预测

2024 年数位糖尿病管理市场估值为 171.1 亿美元，预计 2024 年至 2031 年复合年增长率为 13.10%，到 2031 年将达到 464.6 亿美元。数位糖尿病管理是利用数位技术和连接设备来监测、管理和治疗糖尿病，为患者和医疗保健提供者提供即时数据和见解。这些解决方案包括从智慧血糖仪到胰岛素输送系统等各种产品，旨在改善血糖控制、增强患者参与度并降低糖尿病相关併发症的风险。

数位糖尿病管理的未来在于整合人工智慧、机器学习和大数据分析，以提供更个人化和预测性的护理，从而可能彻底改变糖尿病的治疗和预防策略。

全球数位糖尿病管理市场动态

塑造全球数位糖尿病管理市场的关键市场动态是：

主要市场驱动因子

糖尿病盛行率增加：

全球糖尿病患者数量激增，尤其是在新兴市场，增加了对高效数位管理工具的需求，以有效监测和管理病情，从而推动市场成长。

技术进步：

感测器、行动技术和数据分析的技术创新显着改善了数位糖尿病管理工具，使患者和医疗保健提供者更易于使用、更准确、更有效率。

连接设备的普及：

智慧型手机和穿戴式科技的普及将推动数位糖尿病管理解决方案的采用，加强患者和医疗保健专业人员之间的沟通，并实现更好的护理协调。

关注预防保健：

向预防性医疗保健和个人化医疗的转变正在增加数位工具的使用，以进行糖尿病的早期检测和预防性管理，这有望减少长期併发症并改善患者的治疗结果。

主要问题

资料隐私与安全问题：

敏感健康资料的收集和传输会带来严重的隐私和网路安全问题，并可能阻碍全球糖尿病数位管理市场的成长。

监理障碍：

各地区对医疗设备和软体的严格监管要求可能会延迟产品批准和市场进入，给寻求实施创新糖尿病管理解决方案的公司带来挑战。

主要趋势：

人工智慧整合：

将人工智慧和机器学习融入糖尿病管理工具中，可提供预测性见解和个人化建议，从而提高这些解决方案的有效性和使用者体验。

远距医疗的兴起：

在 COVID-19 大流行的推动下，远距医疗的接受度不断提高，正在推动数位糖尿病管理解决方案中远端监控和虚拟咨询功能的采用，以增强患者护理。

生态系方法：

越来越多的公司正在采用全面的生态系统方法进行糖尿病管理，各整合种设备、应用程式和服务，为患者提供全面、协调的护理体验。

目录

第1章 全球数位糖尿病管理市场:简介

• 市场定义
• 市场区隔
• 调查时间轴
• 前提条件
• 限制

第2章 检验市场调查的调查手法

• 资料探勘
• 资料的三角测量
• Bottom-Up(由下而上)方法
• Top-Down(由上而下)方法
• 调查的流程
• 产业专家的重要洞察
• 资料来源

第3章 摘要整理

• 市场概要
• 生态学製图
• 绝对的商机
• 市场魅力
• 数位糖尿病管理的全球市场各地区分析(年复合成长率)
• 数位糖尿病管理的全球市场:各产品(金额)
• 数位糖尿病管理的全球市场:各类型(金额)
• 数位糖尿病管理的全球市场:各用途(金额)
• 今后的市场机会
• 全球市场分割
• 产品life line

第4章 数位糖尿病管理的全球市场展望

• 数位糖尿病管理的世界演进
• 促进因素
• 阻碍因素
• 机会
• 波特的五力分析
• 价值链分析
• 价格分析
• 宏观经济分析

第5章 数位糖尿病管理的全球市场:各产品

• 概要
• 智慧血糖计
• 持续血糖监测系统
• 智慧胰岛素笔针
• 智慧胰岛素帮浦
• APPS类

第6章 数位糖尿病管理的全球市场:各类型

• 概要
• 穿戴式设备
• 手持设备

第7章 数位糖尿病管理的全球市场:各终端用户

• 概要
• 医院
• 家庭套组
• 诊断中心

第8章 数位糖尿病管理的全球市场:各地区

• 概要
• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 其他欧洲
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 南美
  • 巴西
  • 阿根廷
  • 其他南美国家
• 中东·非洲
  • 阿拉伯联合大公国
  • 沙乌地阿拉伯
  • 南非
  • 其他中东和非洲

第9章 全球数位糖尿病管理市场:竞争情形

• 概要
• 各公司的市场排行榜
• 主要的发展
• 各地区足迹
• 企业的产业足迹
• ACE MATRIX

第10章 企业简介

• ABBOTT LABORATORIES
• MEDTRONIC PLC
• F. HOFFMANN-LA ROCHE LTD.
• BAYER AG
• LIFESCAN, INC.
• DEXCOM, INC.
• SANOFI
• INSULET CORPORATION
• ASCENSIA DIABETES CARE HOLDINGS AG
• B BRAUN MELSUNGEN AG
• ABOUT VERIFIED MARKET RESEARCH
• DYNAMIC DATA VISUALIZATION

Digital Diabetes Management Market Size And Forecast

Digital Diabetes Management Market was valued at USD 17.11 Billion in 2024 and is projected to reach USD 46.46 Billion by 2031 growing at a CAGR of 13.10% from 2024 to 2031. Digital Diabetes Management refers to the use of digital technologies and connected devices to monitor, manage and treat diabetes, providing real-time data and insights to both patients and healthcare providers. These solutions encompass a range of products from smart glucose meters to insulin delivery systems, aiming to improve glycemic control, enhance patient engagement and reduce the risk of diabetes-related complications.

The future scope of digital diabetes management lies in the integration of artificial intelligence, machine learning and big data analytics to provide more personalized and predictive care, potentially revolutionizing diabetes treatment and prevention strategies.

Global Digital Diabetes Management Market Dynamics

The key market dynamics that are shaping the global digital diabetes management market include:

Key Market Drivers:

Rising Prevalence of Diabetes:

The global surge in diabetes cases, especially in developing regions, is increasing the need for efficient digital management tools to monitor and control the condition effectively, boosting market growth.

Technological Advancements:

Innovations in sensors, mobile technology and data analytics are significantly improving digital diabetes management tools, making them more user-friendly, precise and efficient for both patients and healthcare providers globally.

Growing Adoption of Connected Devices:

The widespread use of smartphones and wearable technology is driving greater adoption of digital diabetes management solutions, enhancing communication between patients and healthcare providers for better care coordination.

Focus on Preventive Healthcare:

The shift towards preventive healthcare and personalized medicine is increasing the use of digital tools for early diabetes detection and proactive management, reducing long-term complications and improving patient outcomes.

Key Challenges:

Data Privacy and Security Concerns:

The collection and transmission of sensitive health data pose significant privacy and cybersecurity concerns, which can hinder the growth of the global diabetes digital management market.

Regulatory Hurdles:

Strict regulatory requirements for medical devices and software across various regions can delay product approvals and market entry, creating challenges for companies aiming to introduce innovative diabetes management solutions.

Key Trends:

Integration of Artificial Intelligence:

The incorporation of artificial intelligence and machine learning into diabetes management tools is providing predictive insights and personalized recommendations, enhancing the effectiveness and user experience of these solutions.

Rise of Telemedicine:

The growing acceptance of telemedicine, accelerated by the COVID-19 pandemic, is significantly driving the adoption of remote monitoring and virtual consultation features within digital diabetes management solutions for enhanced patient care.

Ecosystem Approach:

Companies are increasingly adopting a comprehensive ecosystem approach in diabetes management, integrating various devices, applications and services to provide a holistic and coordinated care experience for patients.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Digital Diabetes Management Market Regional Analysis

Here is a more detailed regional analysis of the global digital diabetes management market:

North America:

According to Verified Market Research, North America is expected to dominate the Global digital diabetes management market.

The region benefits from advanced healthcare infrastructure, high diabetes prevalence and early adoption of digital health technologies, driving its market dominance in the sector.

Strong presence of major market players and favorable reimbursement policies in countries like the U.S. and Canada contribute to the region's leading position.

The growing emphasis on value-based care and patient-centric approaches in North America supports the adoption of digital diabetes management solutions.

Increasing investments in digital health startups and collaborations between technology companies and healthcare providers fuel innovation in the region.

Asia-Pacific:

According to Verified Market Research, Asia-Pacific is the fastest growing region in Global digital diabetes management market.

The Asia-Pacific region is experiencing a rapid increase in diabetes prevalence, creating a significant demand for effective management solutions.

Rising disposable incomes, improving healthcare infrastructure and increasing awareness about diabetes management in countries like China and India drive market growth.

Government initiatives to promote digital health and improve diabetes care in several Asian countries contribute to the rapid adoption of digital management tools.

The large population base and increasing penetration of smartphones and internet connectivity in the region support the swift market expansion.

Global Digital Diabetes Management Market Segmentation Analysis

The Global Digital Diabetes Management Market is Segmented on the Basis of Product, Type, End-User, And Geography.

Digital Diabetes Management Market, By Product

• Smart Glucose Meters
• Continuous Glucose Monitoring Systems
• Smart Insulin Pens
• Smart Insulin Pumps
• Others

Based on Product, the Digital Diabetes Management market is segmented into Smart Glucose Meters, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps and Others. Continuous Glucose Monitoring Systems (CGMs) are the most dominating product segment, driven by their ability to provide real-time, continuous glucose data without the need for frequent finger pricks. The increasing preference for CGMs among both Type 1 and Type 2 diabetes patients, coupled with their integration with insulin delivery systems, contributes significantly to their market dominance.

Digital Diabetes Management Market, By Type

• Wearable Devices
• Handheld Devices

Based on Type, the Digital Diabetes Management market is categorized into Wearable Devices and Handheld Devices. Wearable Devices are the most dominating type, driven by their convenience, continuous monitoring capabilities and seamless integration with smartphones and other connected devices. The growing consumer preference for non-invasive and discreet monitoring solutions, along with advancements in sensor technologies, supports the dominance of wearable devices in the digital diabetes management market.

Digital Diabetes Management Market, By End-User

• Hospitals & Specialty Clinics
• Home Care Settings
• Academic & Research Institutes

Based on End-User, the Digital Diabetes Management market is segmented into Hospitals & Specialty Clinics, Home Care Settings and Academic & Research Institutes. Home Care Settings is the most dominating end-user segment, driven by the increasing trend towards self-management of diabetes and the growing preference for remote monitoring solutions. The convenience and cost-effectiveness of managing diabetes at home, coupled with the rising adoption of telemedicine, contribute significantly to the dominance of this segment.

Digital Diabetes Management Market, By Component

• Devices
• Apps & Software
• Services

Based on Component, the Digital Diabetes Management market is segmented into Devices, Apps & Software and Services. Devices are the most dominating component, driven by the essential role of hardware in glucose monitoring and insulin delivery. The continuous innovations in device technologies, such as improved accuracy, miniaturization and connectivity features, support their significant market share and dominance in the digital diabetes management ecosystem.

Digital Diabetes Management Market, By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Based on Geography, the Digital Diabetes Management market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa. North America is both the largest and one of the fastest-growing regions, driven by high diabetes prevalence, advanced healthcare infrastructure and early adoption of digital health technologies. The region's strong focus on innovation, favorable reimbursement policies and presence of key market players contribute significantly to its market dominance and continued rapid growth.

Key Players

• The Global "Digital Diabetes Management Market" study report will provide valuable insight with an emphasis on the global market. The major players in the Digital Diabetes Management Market include
• Medtronic, Dexcom, Inc., Insulet Corporation, Abbott Laboratories, Tandem Diabetes Care, Lifescan, Inc., Ascensia Diabetes Care, Tidepool, Glooko, Inc. and H2 Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above- mentioned players globally.

• Digital Diabetes Management Market Recent Developments
• In January 2024, Medtronic launched an advanced closed-loop insulin delivery system with enhanced AI capabilities, aiming to improve glucose control and reduce the burden of diabetes management for patients.
• In March 2024, Dexcom, Inc. announced a partnership with a major telehealth provider to integrate its CGM data into virtual diabetes care platforms, expanding access to remote monitoring and management services.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL DIGITAL DIABETES MANAGEMENT MARKET

• 1.1 MARKET DEFINITION
• 1.2 MARKET SEGMENTATION
• 1.3 RESEARCH TIMELINES
• 1.4 ASSUMPTIONS
• 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 2.1 DATA MINING
• 2.2 DATA TRIANGULATION
• 2.3 BOTTOM-UP APPROACH
• 2.4 TOP-DOWN APPROACH
• 2.5 RESEARCH FLOW
• 2.6 KEY INSIGHTS FROM INDUSTRY EXPERTS
• 2.7 DATA SOURCES

3 EXECUTIVE SUMMARY

• 3.1 MARKET OVERVIEW
• 3.2 ECOLOGY MAPPING
• 3.3 ABSOLUTE MARKET OPPORTUNITY
• 3.4 MARKET ATTRACTIVENESS
• 3.5 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
• 3.6 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT (USD MILLION)
• 3.7 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE (USD MILLION)
• 3.8 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY APPLICATION (USD MILLION)
• 3.9 FUTURE MARKET OPPORTUNITIES
• 3.10 GLOBAL MARKET SPLIT
• 3.11 PRODUCT LIFE LINE

4 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET OUTLOOK

• 4.1 GLOBAL DIGITAL DIABETES MANAGEMENT EVOLUTION
• 4.2 DRIVERS
  • 4.2.1 DRIVER 1
  • 4.2.2 DRIVER 2
• 4.3 RESTRAINTS
  • 4.3.1 RESTRAINT 1
  • 4.3.2 RESTRAINT 2
• 4.4 OPPORTUNITIES
  • 4.4.1 OPPORTUNITY 1
  • 4.4.2 OPPORTUNITY 2
• 4.5 PORTERS FIVE FORCE MODEL
• 4.6 VALUE CHAIN ANALYSIS
• 4.7 PRICING ANALYSIS
• 4.8 MACROECONOMIC ANALYSIS

5 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY PRODUCT

• 5.1 OVERVIEW
• 5.2 SMART GLUCOSE METER
• 5.3 CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEM
• 5.4 SMART INSULIN PENS
• 5.5 SMART INSULIN PUMPS
• 5.6 APPS

6 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY TYPE

• 6.1 OVERVIEW
• 6.2 WEARABLE DEVICES
• 6.3 HANDHELD DEVICES

7 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY END-USER

• 7.1 OVERVIEW
• 7.2 HOSPITALS
• 7.3 HOME SETTINGS
• 7.4 DIAGNOSTIC CENTERS EXTERIOR

8 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET, BY GEOGRAPHY

• 8.1 OVERVIEW
• 8.2 NORTH AMERICA
  • 8.2.1 U.S.
  • 8.2.2 CANADA
  • 8.2.3 MEXICO
• 8.3 EUROPE
  • 8.3.1 GERMANY
  • 8.3.2 U.K.
  • 8.3.3 FRANCE
  • 8.3.4 ITALY
  • 8.3.5 SPAIN
  • 8.3.6 REST OF EUROPE
• 8.4 ASIA PACIFIC
  • 8.4.1 CHINA
  • 8.4.2 JAPAN
  • 8.4.3 INDIA
  • 8.4.4 REST OF ASIA PACIFIC
• 8.5 LATIN AMERICA
  • 8.5.1 BRAZIL
  • 8.5.2 ARGENTINA
  • 8.5.3 REST OF LATIN AMERICA
• 8.6 MIDDLE-EAST AND AFRICA
  • 8.6.1 UAE
  • 8.6.2 SAUDI ARABIA
  • 8.6.3 SOUTH AFRICA
  • 8.6.4 REST OF MIDDLE-EAST AND AFRICA

9 GLOBAL DIGITAL DIABETES MANAGEMENT MARKET COMPETITIVE LANDSCAPE

• 9.1 OVERVIEW
• 9.2 COMPANY MARKET RANKING
• 9.3 KEY DEVELOPMENTS
• 9.4 COMPANY REGIONAL FOOTPRINT
• 9.5 COMPANY INDUSTRY FOOTPRINT
• 9.6 ACE MATRIX

10 COMPANY PROFILES

• 10.1 ABBOTT LABORATORIES
  • 10.1.1 COMPANY OVERVIEW
  • 10.1.2 COMPANY INSIGHTS
  • 10.1.3 PRODUCT BENCHMARKING
  • 10.1.4 KEY DEVELOPMENT
  • 10.1.5 WINNING IMPERATIVES
  • 10.1.6 CURRENT FOCUS & STRATEGIES
  • 10.1.7 THREAT FROM COMPETITION
  • 10.1.8 SWOT ANALYSIS
• 10.2 MEDTRONIC PLC
• 10.3 F. HOFFMANN-LA ROCHE LTD.
• 10.4 BAYER AG
• 10.5 LIFESCAN, INC.
• 10.6 DEXCOM, INC.
• 10.7 SANOFI
• 10.8 INSULET CORPORATION
• 10.9 ASCENSIA DIABETES CARE HOLDINGS AG
• 10.10 B BRAUN MELSUNGEN AG
• 10.11 ABOUT VERIFIED MARKET INTELLIGENCE
• 10.12 DYNAMIC DATA VISUALIZATION